Blog

Gertjan Rasschaert: Digestive Oncology Leuven is well represented at ASCO25

Gertjan Rasschaert/LinkedIn

May 29, 2025, 10:52

Gertjan Rasschaert: Digestive Oncology Leuven is well represented at ASCO25

Gertjan Rasschaert, Medical Doctor and Consultant specializing in Gastrointestinal Oncology and Gastroenterology at UZ Leuven, shared a post on LinkedIn:

“With 3 original abstracts and partaking in 8 clinical trials our UZ Leuven GI oncology team (aka ‘Digestive Oncology Leuven’) is well represented at ASCO25.

Looking forward to meet you in Chicago.”

Gertjan Rasschaert announced that the UZ Leuven gastrointestinal oncology team will be represented at ASCO 2025 with three original abstracts and participation in eight clinical trials.

More posts featuring Gertjan Rasschaert.

ASCO25 cancer Chicago clinical trials Digestive Oncology Leuven fight against cancer Gastrointestinal Oncology Gertjan Rasschaert GI oncology Global fight against cancer OncoDaily Oncology UZ Leuven

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers